The Tampa Bay Times spotlights RxERP’s work on pharmaceutical traceability software, covering a trial that uses a tiny embedded microtransponder (“p‑Chip”) to help verify medication identity and reduce counterfeit risk. The story frames the effort in the context of DSCSA compliance and the limits of labels, barcodes, and traditional RFID, positioning embedded unit-level identity as a more durable chain-of-identity control. For manufacturers, distributors, and pharmacies, the approach supports pharma serialization software goals by linking physical product identity to audit-ready verification events.
Link: https://www.tampabay.com/news/health/2026/01/23/tampa-pharmaceutical-microchip-prescription-drugs/